Strides Pharma Science Limited
http://www.strides.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Strides Pharma Science Limited
AstraZeneca/Sanofi’s RSV Shot Among 13 Hopefuls Awaiting EU Verdict
Its crunch time for sponsors of more than a dozen products as the EMA meets to adopt opinions on several marketing authorization applications.
Strides’ Stelis Wins FDA Approval For Bengalaru Injectables Facility
Stelis BioPharma’s flagship Indian manufacturing facility has been cleared under an FDA Establishment Inspection Report.
Strides Pharma Reaches 9 US OTCs With Naproxen
Recent approval of Indian firm’s ANDA for 220-mg naproxen capsules comes as NDA process for launching OTCs in US soon could take a back seat to overhauled monograph program the pharma industry prepares to start using on 1 October.
Strides’ Stelis Moves Closer To EU Nod For Forteo Biosimilar In FY23
Strides’ biopharma arm Stelis Biopharma has moved closer to approval in the EU and likely the US too for a biosimilar to Eli Lilly’s Forteo in FY23, following GMP certification for its manufacturing units. Meanwhile, merchant bankers have been appointed to evaluate strategic options to raise cash for Stelis.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
-
- Strides Arcolab Ltd.
- Strides Arcolab Limited
- Amneal Pharmaceuticals Pty Limited, Australia
- Faglis Medica Private Limited
- Strides Shasun Limited